Organs-on-chips Market by Type (Artery-on-a-chip, Brain-on-a-chip, Heart-on-a-chip), Application (Drug Discovery, Physiological Model Development, Toxicology Research), End User - Global Forecast 2024-2030

Organs-on-chips Market by Type (Artery-on-a-chip, Brain-on-a-chip, Heart-on-a-chip), Application (Drug Discovery, Physiological Model Development, Toxicology Research), End User - Global Forecast 2024-2030


The Organs-on-chips Market size was estimated at USD 48.61 million in 2023 and expected to reach USD 64.91 million in 2024, at a CAGR 33.60% to reach USD 369.42 million by 2030.

Global Organs-on-chips Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Organs-on-chips Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Organs-on-chips Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Organs-on-chips Market, highlighting leading vendors and their innovative profiles. These include Beonchip S. L., BICO Group AB, BiomimX S.r.l., BIOND Solutions B.V., Cherry Biotech, CN Bio Innovations Limited, Elveflow, InSphero AG, Kirkstall Ltd., MesoBioTech, Micronit B.V., Mimetas B.V., SynVivo, Inc., The Charles Stark Draper Laboratory, Inc., and TissUse GmbH.

Market Segmentation & Coverage

This research report categorizes the Organs-on-chips Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Artery-on-a-chip
Brain-on-a-chip
Heart-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Skin-on-a-chip
Application
Drug Discovery
Physiological Model Development
Toxicology Research
End User
Academic & Research Institutes
Cosmetics Industry
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Organs-on-chips Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Organs-on-chips Market?
3. What are the technology trends and regulatory frameworks in the Organs-on-chips Market?
4. What is the market share of the leading vendors in the Organs-on-chips Market?
5. Which modes and strategic moves are suitable for entering the Organs-on-chips Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Organs-on-chips Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing focus on developing alternatives for animal testing models
5.1.1.2. Rising need for early detection of drug toxicity to minimize financial losses
5.1.1.3. Growing initiatives to increase awareness about organs-on-chips technologies
5.1.2. Restraints
5.1.2.1. Issues related to the incorporation of organs-on-chips technologies into existing workflows
5.1.3. Opportunities
5.1.3.1. Application of organs-on-chips in oncology research
5.1.3.2. Development of multiple-organs-on-a-chip models
5.1.4. Challenges
5.1.4.1. Biological and technological complexities of organs-on-chips models
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Organs-on-chips Market, by Type
6.1. Introduction
6.2. Artery-on-a-chip
6.3. Brain-on-a-chip
6.4. Heart-on-a-chip
6.5. Kidney-on-a-chip
6.6. Lung-on-a-chip
6.7. Skin-on-a-chip
7. Organs-on-chips Market, by Application
7.1. Introduction
7.2. Drug Discovery
7.3. Physiological Model Development
7.4. Toxicology Research
8. Organs-on-chips Market, by End User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Cosmetics Industry
8.4. Pharmaceutical & Biotechnology Companies
9. Americas Organs-on-chips Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Organs-on-chips Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Organs-on-chips Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Beonchip S. L.
13.1.2. BICO Group AB
13.1.3. BiomimX S.r.l.
13.1.4. BIOND Solutions B.V.
13.1.5. Cherry Biotech
13.1.6. CN Bio Innovations Limited
13.1.7. Elveflow
13.1.8. InSphero AG
13.1.9. Kirkstall Ltd.
13.1.10. MesoBioTech
13.1.11. Micronit B.V.
13.1.12. Mimetas B.V.
13.1.13. SynVivo, Inc.
13.1.14. The Charles Stark Draper Laboratory, Inc.
13.1.15. TissUse GmbH
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. ORGANS-ON-CHIPS MARKET RESEARCH PROCESS
FIGURE 2. ORGANS-ON-CHIPS MARKET SIZE, 2023 VS 2030
FIGURE 3. ORGANS-ON-CHIPS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ORGANS-ON-CHIPS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ORGANS-ON-CHIPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ORGANS-ON-CHIPS MARKET DYNAMICS
FIGURE 7. ORGANS-ON-CHIPS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. ORGANS-ON-CHIPS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. ORGANS-ON-CHIPS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. ORGANS-ON-CHIPS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ORGANS-ON-CHIPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ORGANS-ON-CHIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ORGANS-ON-CHIPS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ORGANS-ON-CHIPS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings